Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>To investigate the abnormalities of the upper gastrointestinal tract in liver transplant (LT) recipients, especially the prevalence of <i>Helicobacter pylori (H. pylori)</i> infection and the incidence of chronic atrophic gastritis (CAG), and to explore the efficacy and safety of <i>H. pylori</i> eradication treatment. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Endoscopic screening was performed prospectively on LT recipients who received regular follow‐up in our center. A group of healthy subjects with same age and sex was selected as a control group at a ratio of 1:3 with propensity score matching. All <i>H. pylori</i>‐positive recipients received Bismuth‐containing quadruple therapy (esomeprazole 20 mg + clarithromycin 500 mg + amoxicillin 1 g + bismuth 220 mg, all of the medicines were applied twice daily, for 14 days). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Result</h3><p>The prevalence of <i>H. pylori</i> infection was significantly lower in LT group than control group [12/102(11.8%) vs 98/306(32.0%), P<0.001], whereas the prevalence of CAG was similar between the two groups [48/102 (47.1%)vs 138/306(45.1%), P=0.731]. Meanwhile, the incidence of reflux esophagitis [18/102 (17.6%)vs 31/306(10.1%), P=0.043] and bile regurgitation [19/102(18.6%) vs 30/306(9.8%), P=0.018] were higher in LT group. No correlation between the incidence of upper gastroduodenal abnormalities and postoperative time after liver transplantation was found. The success rate of <i>H. pylori</i> eradication therapy was 100% (10/10). The blood concentration of immunosuppressants was 1.7 to 3.6 times above baseline values during <i>H. pylori</i> eradication therapy, however, no severe adverse effects were observed during the proceed with dose adjustments of the immunosuppressants. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Although the prevalence of <i>H. pylori</i> infection was lower in LT recipients than in control subjects, the prevalence of CAG was like that of the general population. <i>H. pylori</i> eradication therapy was safe and effective after liver transplantation in our preliminary study. </p></section>

The Different Strain Infection of Helicobacter Pylori in Cirrhotic Patients

A Clinical Study on Relationship Between Liver Cirrhosis and Helicobacter Pylori

Cytotoxin Associated Protein Gene,vacuolating Cytoxin Gene and Expression Production of Helicobacter Pylori Correlative with Gastroduodenal Disease in Children

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Changes in Serum Ammonia Concentration in Cirrhotic Patients with Helicobacter Pylori Infection

Helicobacter Pylori Infection in Cholangiocarcinoma Tissues

[The Effects of Helicobacter Pylori Infection on Hyperammonaemia and Hepatic Encephalopathy in Cirrhotic Patients].

Influence of Helicobacter Pylori Infection on Blood Ammonia Concentration in Patients with Hepatic Cirrhosis

Serum ammonia levels in patients with chronic hepatitis B and their relation with Helicobacter pylori infection

Effect of H Pylori Infection and Its Eradication on Hyperammo-Nemia and Hepatic Encephalopathy in Cirrhotic Patients

Analysis of Infection of Helicobacter Pylori in Patients with Extra-Gastrointestinal Diseases

Effects of Infection with Different Types of Helicobacter pylori on Gastric Secretion Function: A Cross-Sectional Clinical Study

Study on Relationship Between Infection of Helicobacter Pylori,caga-Hp,and Gastric Diseases

Chronic atrophic gastritis and Helicobacter pylori infection status in liver transplant recipients

Effects of the eradication of H pylori in patients with liver cirrhosis and hyperammonaemia

The Study on Difference Between Two Helicobacter Pylori Eradication Treatments for Patients with Peptic Ulcer Disease and Non-Ulcer Dyspepsia

Study on Relationship Between Infection of Helicobacter Pylori,caga~+-Hp and Gastric Diseases

Status and influence factors of helicobacter pylori infection in patients taking non-steroidal antiinflammatory drugs in Beijing

Study on the Relationship Between Antibodies to Helicobacter Pylori Virulence Factors and Upper GI Tract Disease

[A Study on the Relationship of Helicobacter Pylori, Gastrin and Gastroesophageal Reflux Disease].

Correlations of Helicobacter pylori Infection with Portal Hypertensive Gastropathy and Its Complicated Upper Gastrointestinal Hemorrhage in Patients with Liver Cirrhosis